VERAXA Biotech AG (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, has announced the appointment of Raju Willener as chief financial officer, effective immediately. Willener brings more than three decades of international financial leadership experience spanning global capital markets, investment banking, corporate finance, asset management, and strategic leadership. He will report to CEO and Co-Founder Christoph Antz, Ph.D., and is expected to support the company’s capital strategy, strategic opportunities, and continued development of its proprietary BiTAC(R) technology platform and oncology pipeline.
The appointment comes at a critical juncture for VERAXA as it advances its pipeline of bispecific T cell engagers, bispecific ADCs, and other innovative antibody formats. Willener’s extensive background in capital markets and corporate finance will be instrumental in guiding the company’s financial strategy and positioning it for future growth. Prior to joining VERAXA, Willener served as director of corporate development at Exentis Group AG before being appointed CFO in 2025, where he led M&A initiatives, financial strategy, and key corporate functions. Earlier in his career, he held senior executive and investment positions overseeing areas including corporate finance, capital markets, investor relations, and investment portfolios exceeding CHF 30 billion in assets under management.
This leadership addition signals VERAXA’s intent to strengthen its financial foundation as it moves its proprietary BiTAC formats and ADCs toward clinical development. The company was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technology. BiTAC(R) is a registered trademark of VERAXA Biotech GmbH.
Investors and stakeholders can view the full press release for more details at https://nnw.fm/jcHOU. For the latest news and updates relating to VRXA, visit the company’s newsroom at http://nnw.fm/VRXA.
